Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
725.9 GBX | -0.78% | -3.65% | -17.99% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- With a P/E ratio at 9.85 for the current year and 8.83 for next year, earnings multiples are highly attractive compared with competitors.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-17.99% | 25.51B | A- | ||
+7.62% | 50.45B | B | ||
+5.93% | 49.81B | B+ | ||
+21.55% | 46.31B | B+ | ||
+13.62% | 42.31B | B+ | ||
+23.63% | 39.83B | B | ||
-1.75% | 28.46B | B | ||
-8.98% | 27.07B | B- | ||
+27.21% | 26.32B | A | ||
+39.17% | 24.17B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PRU Stock
- Ratings Prudential plc